The long-range goal of this research is to regulate the loss of nitrogen, wasting complications and tissue destruction associated with the juvenile-onset insulin-dependent form of diabetes mellitus and other diseases. Our approach is to identify and characterize cellular proteinases and mechanisms used by living systems to degrade cellular proteins and regulate the rate of degradation of proteins in general and specific enzymes according to the metabolic needs of the organism. Aspects of this goal include determination of the initial or rate-limiting steps in the process of enzyme degradation, the influence of hormones on protein turnover and the identification of cellular proteinases active in normal and diseased states. Our working hypothesis based on previous studies is that the mechanisms regulating the degradative process involve factors that alter the conformation of cellular proteins. In this proposed project, liver arginase and muscle aldolase will be used as model cytosolic proteins to determine how the diabetic state and ligands that interact with proteins alter the turnover of enzymes. The synthesis and degradation of arginase and aldolase and the physical-chemical properties of these enzymes from normal and diabetic animals will be studied. We will investigate the interaction of aldolase and arginase with ligands that may regulate protein conformation (branched chain amino acids, disulfides, nucleotides) and determine how the concentrations of these ligands change in tissues with altered rates of degradation. In addition, we recently discovered the first heritable deficiency of a mammalian cellular proteinase; a kidney brush-border metallo-endoproteinase, meprin, is lacking in certain inbred strains of mice. This discovery creates the opportunity to determine the molecular basis of a unique cellular proteinase deficiency. In addition, we plan to investigate the possible role of the proteinase in peptide hormone degradation, in kidney protein degradation and in diabetic nephropathy. Renal complications in diabetes mellitus in man are among the most serious; our studies with diabetic mice will aim to determine whether the kidney proteinases play a role in the pathogenesis of renal disease. These studies have both biological and medical significance and will add to our knowledge of the role of proteinases and mechanisms of protein turnover in mammalian cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK019691-10
Application #
3226505
Study Section
Metabolism Study Section (MET)
Project Start
1977-01-01
Project End
1989-01-31
Budget Start
1986-02-01
Budget End
1987-01-31
Support Year
10
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Overall Medical
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Bylander, John E; Ahmed, Faihaa; Conley, Sabena M et al. (2017) Meprin Metalloprotease Deficiency Associated with Higher Mortality Rates and More Severe Diabetic Kidney Injury in Mice with STZ-Induced Type 1 Diabetes. J Diabetes Res 2017:9035038
Keiffer, Timothy R; Bond, Judith S (2014) Meprin metalloproteases inactivate interleukin 6. J Biol Chem 289:7580-8
Jefferson, Tamara; Auf dem Keller, Ulrich; Bellac, Caroline et al. (2013) The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin ? and ADAM10. Cell Mol Life Sci 70:309-33
Bao, Jialing; Yura, Renee E; Matters, Gail L et al. (2013) Meprin A impairs epithelial barrier function, enhances monocyte migration, and cleaves the tight junction protein occludin. Am J Physiol Renal Physiol 305:F714-26
Garcia-Caballero, Agustin; Ishmael, Susan S; Dang, Yan et al. (2011) Activation of the epithelial sodium channel by the metalloprotease meprin * subunit. Channels (Austin) 5:14-22
Banerjee, Sanjita; Jin, Ge; Bradley, S Gaylen et al. (2011) Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 300:G273-82
Ongeri, Elimelda Moige; Anyanwu, Odinaka; Reeves, W Brian et al. (2011) Villin and actin in the mouse kidney brush-border membrane bind to and are degraded by meprins, an interaction that contributes to injury in ischemia-reperfusion. Am J Physiol Renal Physiol 301:F871-82
Jefferson, Tamara; ?auševi?, Mirsada; auf dem Keller, Ulrich et al. (2011) Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo. J Biol Chem 286:27741-50
Banerjee, S; Oneda, B; Yap, L M et al. (2009) MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease. Mucosal Immunol 2:220-31
Sun, Qi; Jin, Hong-Jian; Bond, Judith S (2009) Disruption of the meprin alpha and beta genes in mice alters homeostasis of monocytes and natural killer cells. Exp Hematol 37:346-56

Showing the most recent 10 out of 15 publications